Schedule a Call Back
Poly Medicure calls for import substitution in upcoming Budget; Himanshu Baid
Industry News- Jul 16,24
Currently around 70% of medical devices and equipment worth nearly Rs 500 billion used in India are imported. The current duty structure for these imports ranges from 7.5% to 10%.
Himanshu Baid , Managing Director, Delhi-based medical devices company Poly Medicure's sees the need for more focused efforts on the ‘Make in India’ initiative, and import substitution in the upcoming Budget.
The government is likely to include a new scheme to boost medical device manufacturing in Budget 2024, and sources the source that the scheme will be aimed at improving quality and reducing dependence of imports.
Baid pointed out that the previous PLI scheme was not fully utilised and called for a new, more comprehensive PLI scheme.
"I think the Production Linked Incentive (PLI) needs to be expanded... The government should add a new PLI, especially for our products which are imported into the country. If we can add another Rs 10-15 billion by a new PLI scheme, I think that will go a long way in boosting manufacturing within the country."
Baid pointed out that currently around 70% of medical devices and equipment worth nearly Rs 500 billion used in India are imported.
The current duty structure for these imports ranges from 7.5% to 10%.
He also highlighted the need for increased incentives for research and development (R&D) and exports, as the current incentives are minimal and insufficient to attract large multinational companies to India as a manufacturing base.
He believes the current import duty structure is appropriate and should remain unchanged, given India's significant reliance on healthcare imports. Immediate changes are not feasible, so a gradual approach is necessary.
The company has a market capitalisation of Rs 203 billion. Its shares have risen 91% over the last year.
(Source: CNBCTV18)
Related Stories
Electrical & Electronics
India to introduce import limits on laptops, tablets, PCs in 2025
Currently, India permits unrestricted imports of these products, but the proposed limits could reshape the $10 billion IT hardware market, which is highly import-reliant.
Read moreProcess Equipment
India levies anti-dumping duty on chemical imports from China, Korea & Thailand
The decision follows a recommendation by the Directorate General of Trade Remedies (DGTR) under the Commerce Ministry, which found that Epichlorohydrin was being sold in India below standard prices ..
Read moreProcess Equipment
Medical device sector applauds Centre's Rs 5 billion boost
The medical device market in India, valued at around $14 billion, is anticipated to grow to $30 billion by 2030, underscoring its importance in healthcare, from diagnostic tools to surgical devices.
Read moreRelated Products
latest News
Subscribe to iNoW
For Industry News on WhatsApp, Give a Miss Call on: +91 84228 74016
